Resumen
Objetivo: Identificar los factores de riesgo para la infección por Clostridrioides difficile (ICD) en pacientes adultos en unidades de cuidados intensivos. Métodos: Revisión integrativa de la literatura, realizada a través de una búsqueda en la base de datos PubMed, siendo incluido artículos que evaluaran los factores de riesgo para ICD en pacientes hospitalizados en unidades de cuidados intensivos. Las palabras clave utilizadas fueron “Clostridioides difficile”, “risk factors” y “intensive care units”. Resultados: La búsqueda resultó en 74 artículos, 23 fueron preseleccionados para lectura y análisis, de estos, 11 fueron excluidos de acuerdo el objetivo y criterios de inclusión, siendo 12 artículos incluidos. Consideraciones finales: Los factores de riesgo para ICD son el uso de antibióticos de amplio espectro, hospitalización prolongada, permanencia en unidades de cuidados intensivos, enfermedad grave, edad avanzada, terapia inmunosupresora, nutrición enteral, inhibidores de la bomba de protones, presencia de comorbilidades y trastornos metabólicos. El conocimiento de estos factores es imprescindible a la prevención y al buen manejo terapéutico de los pacientes hospitalizados, sobre todo en unidades de cuidados intensivos.
Referencias
ANTONELLI M, et al. Clostridioides difficile (formerly Clostridium difficile) infection in the critically ill: an expert statement. Intensive Care MedicineSpringer, 2020; 46(2): 5873.
BALSELLS E, et al. Global burden of Clostridium difficile infections: A systematic review and meta-analysis. Journal of Global Health, 2019; 9(1): 10407.
BLOT S, et al. Healthcare-associated infections in adult intensive care unit patients: Changes in epidemiology, diagnosis, prevention and contributions of new technologies. Intensive and Critical Care Nursing, 2022; 70: 103227.
BUDDLE JE e FAGAN RP. Pathogenicity and virulence of Clostridioides difficile. Virulence Taylor and Francis Ltd, 2023; 10(1): 2150452.
CHAPELA S, et al. Prevalencia de diarrea en pacientes adultos en terapia intensiva y su relación con las fórmulas enterales listas para utilizar. Revista de la Facultad de Ciencias Médicas de Córdoba, 2022; 79(3): 36975.
CUI Y, et al. Risk factors for Clostridioides difficile infection and colonization among patients admitted to an intensive care unit in Shanghai, China. BMC Infectious Diseases, 2019; 19(1): 961.
DEL VECCHIO LE, et al. Risk Factors, Diagnosis, and Management of Clostridioides difficile Infection in Patients with Inflammatory Bowel Disease. Microorganisms, 2022; 10(7): 1315.
FEUERSTADT P, et al. Mortality, Health Care Use, and Costs of Clostridioides difficile Infections in Older Adults. Journal of the American Medical Directors Association, 2022; 23(10): 153.
HEIMANN SM, et al. Economic burden and cost-effective management of Clostridium difficile infections. Medecine et Maladies Infectieuses, 2018; 48(1): 23-29.
KAABIA NM, et al. Epidemiology of Clostridioides difficile infection at a tertiary care facility in Saudi Arabia. Saudi Medical Journal, 2024; 45(2): 188-193.
KARAOUI WR, et al. Incidence, outcome, and risk Incidence, outcome, and risk factors for recurrence of nosocomial Clostridioides difficile infection in adults: A prospective cohort study. Journal of Infection and Public Health, 2020; 13(4): 485–490.
KASSEM S, et al. Clinical outcomes of clostridioides difficile infection in the very elderly. Internal and Emergency Medicine, 2024; 19(4): 1041-1049.
KIM SM, et al. Impact of chronic kidney disease on clinical outcomes in diabetic patients undergoing percutaneous coronary intervention in the era of newer-generation drug-eluting stents. Korean Circulation Journal, 2017; 47(2): 312.
LEE JC, et al. Severe Clostridium difficile infections in intensive care units: Diverse clinical presentations. Journal of Microbiology, Immunology and Infection, 2021; 54(6): 1111–1117.
LESSA FC, et al. Burden of Clostridium difficile Infection in the United States. New England Journal of Medicine, 2015; 372(9): 825–834.
LI C, et al. Incidence and outbreak of healthcare-onset healthcare-associated Clostridioides difficile infections among intensive care patients in a large teaching hospital in China. Frontiers in Microbiology, 2018; 9: 566.
MADA PK e ALAM MU. Clostridioides difficile Infection. StatPearls Publishing, 2023.
MATTHAIOU DK, et al. Characteristics, risk factors and outcomes of Clostridium difficile infections in Greek Intensive Care Units. Intensive and Critical Care Nursing, 2019; 53: 73–78.
MENG X, et al. Antibiotic Resistances and Molecular Characteristics of Clostridioides difficile in ICUs in a Teaching Hospital From Central South China. Frontiers in Medicine, 2021; 8: 745383.
MI H, et al. Colonization of Toxigenic Clostridium difficile Among Intensive Care Unit Patients: A Multi-Centre Cross-Sectional Study. Frontiers in Cellular and Infection Microbiology, 2020; 10: 12.
MOREELS T, et al. Self-Management Interventions for Facilitating Life Participation for Persons with Kidney Failure A Systematic Review. Clinical Journal of the American Society of Nephrology, 2024; 19(2): 189–201.
TAY HL, et al. Risk factors and treatment outcomes of severe Clostridioides difficile infection in Singapore. Scientific Reports,2019; 9(1): 13440.
WANG D, et al. Risk factors and intestinal microbiota: Clostridioides difficile infection in patients receiving enteral nutrition at Intensive Care Units. Critical Care, 2020; 24(1): 426.
WORLEY J, et al. Genomic Determination of Relative Risks for Clostridioides difficile Infection from Asymptomatic Carriage in Intensive Care Unit Patients. Clinical Infectious Diseases, 2021; 73(7): 1727–1736.
